As a fragment of growth hormone that specifically targets fat metabolism, it appears to avoid many of the side effects associated with full growth hormone therapy, such as joint pain, fluid retention, and effects on glucose metabolism
Use of this information is at your own risk, and we are not liable for any outcomes resulting from its use.
(Youre going to get blitzed, Koniver remembers Huberman saying.) On the podcast, Koniver said that almost everyone I could think of can benefit from peptides, and he highlighted an awesome, supersafe example called BPC-157
and with KPV, renowned for its anti-inflammatory and antimicrobial properties
To offset these pressures, Ipsen has successfully launched Iqirvo (elafibranor) for primary biliary cholangitis and Bylvay (odevixibat) for rare liver diseases, and acquired multiple innovative pipeline assets in 2024